The roles of microRNAs in atherosclerosis

Current Medicinal Chemistry

Volumn 21, Issue 13, 2014, Pages 1531-1543

  Lu, Xinjie ^a   Kakkar, Vijay ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Atherosclerosis; Autoantibodies; MicroRNA; Toll like receptor and inflammatory

Indexed keywords

INTERFERON; MICRORNA; SMALL UNTRANSLATED RNA; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIPID TRANSPORT; MACROPHAGE; NEOPLASM; NONHUMAN; REVIEW; VASCULAR SMOOTH MUSCLE; ANIMAL; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION;

EID: 84899886130     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666131218100606     Document Type: Review

References (153)

1. Hansson, G.K.; Hermansson, A. The immune system in atherosclerosis. Nat. Immunol., 2011, 12, 204-212.
2. Libby, P.; Ridker, P.M.; Hansson, G.K. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, 473, 317-325.
3. Friedman, R.C.; Farh, K.K.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19, 92-105.
4. Chen, K.; Rajewsky, N. The evolution of gene regulation by transcription factors and microRNAs". Nat. Rev. Genet., 2007, 8, 93-103.
5. Hu R, O'Connell RM. MicroRNA control in the development of systemic autoimmunity. Arthritis Res. Ther., 2013, 15, 202.
6. Ylä-Herttuala, S.; Palinski, W.; Butler, S.W.; Picard, S.; Steinberg, D.; Witztum, J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb., 1994, 14, 32-40.
7. Stemme, S.; Faber, B.; Holm, J.; Wiklund, O.; Witztum, J.L.; Hansson, G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA, 1995, 92, 3893-3897.
8. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The, C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 5, 843-854.
9. Lim, L.P.; Lau, N.C.; Garrett-Engele, P.; Grimson, A.; Schelter, J.M.; Castle.; Bartel, D.P.; Linsley, P.S.; Johnson, J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 2005, 433, 769-773.
10. Brennecke, J.; Hipfner, D.R.; Stark, A.; Russell, R.B.; Cohen, S.M. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 2003, 113, 25-36.
11. Poy, M.N.; Eliasson, L.; Krutzfeldt, J.; Kuwajima, S.; Ma, X.; Macdonald, P.E.; Pfeffer, S.; Tuschl, T.; Rajewsky, N.; Rorsman, P.; Stoffel, M. "A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 2004, 432, 226-230.
12. Chen, C.Z.; Li, L.; Lodish, H.F.; Bartel, D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science, 2004, 303, 83-86.
13. Harfe, B.D.; McManus, M.T.; Mansfield, J.H.; Hornstein, E.; Tabin, C.J. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc. Natl. Acad. Sci. USA, 2005, 102, 10898-10903.
14. Lagos-Quintana, M.; Rauhut, R.; Yalcin, A.; Meyer, J.; Lendeckel, W.; Tuschl, T. Identification of tissue-specific microRNAs from mouse. Curr. Biol., 2002, 12, 735-739.
15. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science, 2001, 294, 853-858.
16. Lim, L.P.; Glasner, M.E.; Yekta, S.; Burge, C.B.; Bartel, D.P. Vertebrate microRNA genes. Science, 2003, 299, 1540.
17. Cai, X.; Hagedorn, C.H.; Cullen, B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 2004, 10, 1957-1966.
18. Lee, Y.; Kim, M.; Han, J.; Yeom, K.H.; Lee, S.; Baek, S.H.; Kim, V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO. J., 2004, 23, 4051-4060.
19. Denli, A.M.; Tops, B.B.; Plasterk, R.H.; Ketting, R.F.; Hannon, G.J. Processing of primary microRNAs by the Microprocessor complex. Nature, 2004, 432, 231-235.
20. Gregory, R.I.; Yan, K.P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R. The Microprocessor complex mediates the genesis of microRNAs. Nature, 2004, 32, 235-240.
21. Han, J.; Lee, Y.; Yeom, K.H.; Nam, J.W.; Heo, I.; Rhee, J.K.; Sohn, S.Y.; Cho, Y.; Zhang, B.T.; Kim, V.N. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell, 2006, 125, 887-901.
22. Kim, V.N.; Han, J.; Siomi, M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol., 2009, 10, 126-139.
23. Suárez, Y.; Fernández-Hernando, C.; Yu, J.; Gerber, S.A.; Harrison, K.D.; Pober, J.S.; Iruela-Arispe, M.L.; Merkenschlager, M.; Sessa, W.C. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. USA, 2008, 105, 14082-14087.
24. Poliseno, L.; Tuccoli, A.; Mariani, L.; Evangelista, M.; Citti, L.; Woods, K.; Mercatanti, A.; Hammond, S.; Rainaldi, G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 2006, 108, 3068-3071.
25. Liu, X.; Cheng, Y.; Zhang, S.; Lin, Y.; Yang, J.; Zhang, C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res., 2009, 104, 476-487.
26. Cheng, Y.; Liu, X.; Yang, J.; Lin, Y.; Xu, D.Z.; Lu, Q.; Deitch, E.A.; Huo, Y.; Delphin, E.S.; Zhang, C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res., 2009, 105, 158-166.
27. Grimson, A.; Farh, K.K.; Johnston, W.K.; Garrett-Engele, P.; Lim, L.P.; Bartel, D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell., 2007, 27, 91-105.
28. Fang, Y.; Shi, C.; Manduchi, E.; Civelek, M.; Davies, P.F. MicroRNA- 10a regulation of proinflammatory phenotype in atherosusceptible endothelium in vivo and in vitro. Proc. Natl. Acad. Sc.i USA, 2010, 107, 13450-13455.
29. Hazen, S.L.; Smith, J.D. An antiatherosclerotic signaling cascade involving intestinal microbiota, microRNA-10b, and ABCA1/ABCG1-mediated reverse cholesterol transport. Circ. Res., 2012, 111, 948-950.
30. Porrello, E.R.; Johnson, B.A.; Aurora, A.B.; Simpson, E.; Nam, Y.J.; Matkovich, S.J.; Dorn, G.W.; van Rooij, E.; Olson, E.N. MiR- 15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res., 2011, 109, 670-679.
31. Small, E.M.; Frost, R.J.; Olson, E.N. MicroRNAs add a new dimension to cardiovascular disease. Circulation, 2010, 121, 1022-1032.
32. Hullinger, T.G.; Montgomery, R.L.; Seto, A.G.; Dickinson, B.A.; Semus, H.M.; Lynch, J.M.; Dalby, C.M.; Robinsonm K,; Stack, C.; Latimer, P.A.; Hare, J.M.; Olson, E,N,; van Rooij, E. Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res., 2012, 110, 71-81.
33. Pin, A.L.; Houle, F.; Guillonneau, M.; Paquet, E.R.; Simard, M.J.; Huot, J. miR-20a represses endothelial cell migration by targeting MKK3 and inhibiting p38 MAP kinase activation in response to VEGF. Angiogenesis, 2012, 15, 593-608.
34. Celletti, F.L.; Waugh, J.M.; Amabile, P.G.; Brendolan, A.; Hilfiker, P.R.; Dake, M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med., 2001, 7, 425-429.
35. Doebele, C.; Bonauer, A.; Fischer, A.; Scholz, A.; Reiss, Y.; Urbich, C.; Hofmann, W.K.; Zeiher, A.M.; Dimmeler, S. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood, 2010, 115, 4944-4950.
36. Riveros, F.; Chandra, S.; Finol, E.A.; Gasser, T.C.; Rodriguez, J.F. A Pull-Back Algorithm to Determine the Unloaded Vascular Geometry in Anisotropic Hyperelastic AAA Passive Mechanics. Ann. Biomed. Eng., 2013, 41, 694-708.
37. Khaidakov, M.; Mehta, J.L. Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary Epithelial Cells Partly via Stimulation of MiR-21. PLoS One, 2013, 7, e46973.
38. Tsoyi, K.; Jang, H.J.; Nizamutdinova, I.T.; Park, K.; Kim, Y.M.; Kim, H.J.; Seo, H.G.; Lee, J.H. Chang KC PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3/GATA-6 signaling pathways in TNF- activated human endothelial cells. Atherosclerosis, 2010, 213, 115-121.
39. Park, J.G.; Ryu, S.Y.; Jung, I.H.; Lee, Y.H.; Kang, K.J.; Lee, M.R.; Lee, M.N.; Sonn, S.K.; Lee, J.H.; Lee, H.; Oh, G.T.; Moon, K.; Shim. H. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis, 2013, 226, 356-363.
40. Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; Castoldi, M.; Soutschek, J.; Koteliansky, V.; Rosenwald, A.; Basson, M.A.; Licht, J.D.; Pena, J.T.; Rouhanifard, S.H.; Muckenthaler, M.U.; Tuschl, T.; Martin, G.R.; Bauersachs, J.; Engelhardt, S. MicroRNA- 21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 2008, 456, 980-984.
41. Roy, S.; Khanna, S.; Hussain, S.R.; Biswas, S.; Azad, A.; Rink, C.; Gnyawali, S.; Shilo, S.; Nuovo, G.J.; Sen, C.K. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res., 2009, 82, 21-29.
42. Brønnum, H.; Andersen, D.C.; Schneider, M.; Sandberg, M.B.; Eskildsen, T.; Nielsen, S.B.; Kalluri, R.; Sheikh, S.P. miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty- 1. PLoS One, 2013, 8, e56280
43. Merki, E.; Zamora, M.; Raya, A.; Kawakami, Y.; Wang, J.; Zhang, X.; Burch, J.; Kubalak, S.W.; Kaliman, P.; Izpisua, Belmonte, J.C.; Chien, K.R.; Ruiz-Lozano, P. Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery formation. Proc. Natl. Acad. Sci. USA, 2005, 102, 18455-18460.
44. Zhou, B.; Ma, Q.; Rajagopal, S.; Wu, S.M.; Domian, I.; Rivera- Feliciano, J.; Jiang, D.; von Gise, A.; Ikeda, S.; Chien, K.R.; Pu, W.T. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature, 2008, 454, 109-113.
45. Smith, C.L.; Baek, S.T.; Sung, C.Y.; Tallquist, M.D. Epicardialderived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ. Res., 2011, 108, e15- e26.
46. Ma, F.; Xu, S.; Liu, X.; Zhang, Q.; Xu, X.; Liu, M.; Hua, M.; Li, N.; Yao, H.; Cao, X. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon. Nat. Immunol., 2011, 12, 861-869.
47. Chen, K.C.; Wang, Y.S.; Hu, C.Y.; Chang, W.C.; Liao, Y.C.; Dai, C.Y.; Juo, S.H. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB. J., 2011, 25, 1718-1728.
48. Selzman, C.H.; Shames, B.D.; Reznikov, L.L.; Miller, S.A.; Meng, X.; Barton, H.A.; Werman, A.; Harken, A.H.; Dinarello, C.A.; Banerjee, A. Liposomal delivery of purified inhibitory-B inhibits tumor necrosis factor-induced human vascular smooth muscle proliferation. Circ. Res., 1999, 84, 867-875.
49. Chou, J.; Lin, J.H.; Brenot, A.; Kim, J.W.; Provot, S.; Werb, Z. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat. Cell Biol., 2013, 15, 201-213.
50. Rudra, D.S.; Pal, U.; Maiti, N.C.; Reiter, R.J.; Swarnakar, S. Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site. J. Pineal. Res., 2013, 54, 398-405.
51. Tumaneng, K.; Schlegelmilch, K.; Russell, R.C.; Yimlamai, D.; Basne,t H.; Mahadevan, N.; Fitamant, J.; Bardeesy, N.; Camargo, F.D.; Guan, K.L. YAP mediates crosstalk between the Hippo and PI3K-TOR pathways by suppressing PTEN via miR-29. Nat. Cell Biol., 2012, 14, 1322-1329.
52. Dávalos, A.; Goedeke, L.; Smibert, P.; Ramírez, C.M.; Warrier, N.P.; Andreo, U.; Cirera-Salinas, D.; Rayner, K.; Suresh, U.; Pastor- Pareja, J.C.; Esplugues, E.; Fisher, E.A.; Penalva, L.O.; Moore, K.J.; Suárez, Y.; Lai, E.C.; Fernández-Hernando, C. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. USA, 2011, 108, 9232-9237.
53. Soh, J.; Iqbal, J.; Queiroz, J.; Fernandez-Hernando, C.; Hussain, M.M. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat. Med., 2013, 19, 892-900.
54. Graff, J.W.; Dickson, A.M.; Clay, G.; McCaffrey, A.P.; Wilson, M.E. Identifying functional microRNAs in macrophages with polarized phenotypes. J. Biol. Chem., 2012, 287, 21816-21825.
55. Rayner, K.J.; Suárez, Y.; Dávalos, A.; Parathath, S.; Fitzgerald, M.L.; Tamehiro, N.; Fisher, E.A.; Moore, K.J.; Fernández- Hernando, C. miR-33 contributes to the regulation of cholesterol homeostasis. Science, 2010, 328, 1570-1573.
56. Rayner, K.J.; Sheedy, F.J.; Esau, C.C.; Hussain, F.N.; Temel, R.E.; Parathath, S.; van Gils, J.M.; Rayne,r A.J,; Chang, A.N.; Suarez, Y.; Fernandez-Hernando, C.; Fisher, E.A.; Moore, K.J. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest., 2011, 121, 2921-2931.
57. Rayner, K.J.; Esau, C.C,.; Hussain, F.N.; McDaniel, A.L.; Marshall, S.M.; van Gils, J.M.; Ray, T.D.; Sheedy, F.J.; Goedeke, L.; Liu, X.; Khatsenko, O.G.; Kaimal ,V.; Lees, C.J.; Fernandez- Hernando, C.; Fisher, E.A.; Temel, R.E.; Moore, K.J. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature, 2011, 478, 404-407.
58. Rayner, K.J.; Suárez, Y.; Dávalos, A.; Parathath, S.; Fitzgerald, M.L.; Tamehiro, N.; Fisher, E.A.; Moore, K.J.; Fernández- Hernando. C. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science, 2010, 328, 1566-1569.
59. Marquart, T.J.; Allen, R.M.; Ory. D.S.; Baldán, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad. Sci. USA, 2010, 107, 12228-12232.
60. Horie, T.; Ono, K.; Horiguchi, M.; Nishi, H.; Nakamura, T.; Nagao, K.; Kinoshita, M.; Kuwabara, Y.; Marusawa, H.; Iwanaga, Y.; Hasegawa, K.; Yokode, M.; Kimura, T.; Kita, T. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl. Acad. Sci. USA, 2010, 107, 17321-17326.
61. Näär, A.M. Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question. Arterioscler. Thromb. Vasc. Biol., 2013, 33, 447-448.
62. Horie, T.; Baba, O.; Kuwabara, Y.; Chujo, Y.; Watanabe, S.; Kinoshita, M.; Horiguchi, M.; Nakamura, T.; Chonabayashi, K.; Hishizawa, M.; Hasegawa, K.; Kume, N.; Yokode, M.; Kita, T.; Kimura, T.; Ono, K. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice. J. Am. Heart Assoc., 2012, 1, e003376.
63. Stein, S.; Matter, C.M. Protective roles of SIRT1 in atherosclerosis. Cell Cycle, 2011, 10, 640-647.
64. Ito, T.; Yagi, S.; Yamakuchi, M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun., 2010, 398, 735-740.
65. Raitoharju, E.; Lyytikainen, L.P.; Levula, M.; Oksala, N.; Mennander, A.; Tarkka, M.; Klopp, N.; Illig, T.; Kahonen, M.; Karhunen, P.J.; Laaksonen, R.; Lehtimaki, T. miR-21, miR-210, miR- 34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis, 2011, 219, 211-217.
66. Liu, G.; Friggeri, A.; Yang, Y.; Park, Y.J.; Tsuruta, Y.; Abraham, E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl. Acad. Sci. USA, 2009, 106, 15819-15824.
67. Taganov, K.D.; Boldin, M.P.; Chang, K.J.; Baltimore, D. NFkappaB- dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA, 2006, 103, 12481-12486.
68. O'Neill, L.A.; Sheedy, F.J.; McCoy, C.E. MicroRNAs: the finetuners of Toll-like receptor signalling. Nat. Rev. Immunol., 2011, 11, 163-175.
69. Parmar, K.M.; Larman, H.B.; Dai, G.; Zhang, Y.; Wang, E.T.; Moorthy, S.N.; Kratz, J.R.; Lin, Z.; Jain, M.K.; Gimbrone, M.A. Jr García- Cardeña, G. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest., 2006, 116, 49-58.
70. Atkins, G.B.; Jain, M.K. Role of Krüppel-like transcription factors in endothelial biology. Circ. Res., 2007, 100, 1686-1695.
71. Lan, Q.; Mercurius, K.O.; Davies, P.F. Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress. Biochem. Biophys. Res. Commun., 1994, 201, 950-956.
72. Brand, K.; Page, S.; Rogler, G.; Bartsch, A.; Brandl, R.; Knuechel, R.; Page, M.; Kaltschmidt, C.; Baeuerle, P.A.; Neumeier, D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest., 1996, 97, 1715-1722.
73. Surh, J.; Gu, Y.S.; Decker, E.A.; McClements, D.J. Influence of environmental stresses on stability of O/W emulsions containing cationic droplets stabilized by SDS-fish gelatin membranes. J. Agric. Food Chem., 2005, 53, 4236-4244.
74. Hajra, L.; Evans, A.I.; Chen, M.; Hyduk, S.J.; Collins, T.; Cybulsky, M.I. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl. Acad. Sci. USA, 2000, 97, 9052-9057.
75. Nair, N.; Kumar, S.; Gongora, E.; Gupta, S. Circulating miRNA as novel markers for diastolic dysfunction. Mol. Cell Biochem., 2013, 376, 33-40.
76. Chen, T.; Huang, Z.; Wang, L.; Wang, Y.; Wu, F.; Meng, S.; Wang, C. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc. Res., 2009, 83, 131-139.
77. Huang, R.S.; Hu, G.Q.; Lin, B.; Lin, Z.Y.; Sun, C.C. MicroRNA- 155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J. Investig. Med., 2010, 58, 961-967.
78. Ji, R.; Cheng, Y.; Yue, J.; Yang, J.; Liu, X.; Chen, H.; Dean, D.B.; Zhang, C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res., 2007, 100, 1579-1588.
79. Bidzhekov, K.; Gan, L.; Denecke, B.; Rostalsky, A.; Hristov, M.; Koeppel, T.A.; Zernecke, A.; Weber, C. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb. Haemost., 2012, 107, 619-625.
80. Banerjee, S.; Cui, H.; Xie, N.; Tan, Z.; Yang, S.; Icyuz, M.; Thannickal, V.J.; Abraham, E.; Liu, G. miR-125a-5p regulates differential activation of macrophages and inflammation. J. Biol. Chem., 2013, 288(49), 35428-35436.
81. Sun, X.; Zhang, M.; Sanagawa, A.; Mori, C.; Ito, S.; Iwaki, S.; Satoh, H.; Fujii, S. Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb. J., 2012, 10, 16. doi: 10.1186/1477-9560-10-16.
82. Sun, C.; Alkhoury, K.; Wang, Y.I.; Foster, G.A.; Radecke, C.E.; Tam, K.; Edwards, C.M.; Facciotti, M.T.; Armstrong, E.J.; Knowlton, A.A.; Newman, J.W.; Passerini, A.G.; Simon, S.I. IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal. Circ. Res., 2012, 111, 1054-1064.
83. van Solingen, C.; de Boer, H.C.; Bijkerk, R.; Monge, M.; van Oeveren-Rietdijk, A.M.; Seghers, L.; de Vries, M.R.; van der Veer, E.P.; Quax, P.H.; Rabelink, T.J.; van Zonneveld, A.J. MicroRNA- 126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemia. Cardiovasc. Res., 2011, 92, 449-455.
84. Kin, K.; Miyagawa, S.; Fukushima, S.; Shirakawa, Y.; Torikai, K.; Shimamura, K.; Daimon, T.; Kawahara, Y.; Kuratani, T.; Sawa, Y. Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc., 2012, 1, e000745. doi: 10.1161/JAHA.112.000745.
85. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; Shah, A.; Willeit, J.; Mayr, M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res., 2010, 107, 810-817.
86. Fichtlscherer, S.; Zeiher, AM.; Dimmeler, S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol., 2011, 31, 2383-2390.
87. Schmidt, M.; Paes, K.; De Mazière, A.; Smyczek, T.; Yang, S.; Gray, A.; French, D.; Kasman, I.; Klumperman, J.; Rice, D.S.; Ye, W. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development, 2007, 134, 2913-2923.
88. Harris, T.A.; Yamakuchi, M.; Ferlito, M.; Mendell, J.T.; Lowenstein, C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA, 2008, 105, 1516-1521.
89. Cheng, Y.; Liu, X.; Yang, J.; Lin, Y.; Xu, D.Z.; Lu, Q.; Deitch, E.A.; Huo, Y.; Delphin, E.S.; Zhang, C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ.Res., 2009, 105, 158-166.
90. Wei, Y.; Nazari-Jahantigh, M.; Neth, P.; Weber, C.; Schober, A. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Arterioscler. Thromb. Vasc. Biol., 2013, 33, 449-454.
91. Cordes. K.R.; Sheehy, N.T.; White, M.P.; Berry, E.C.; Morton, S.U.; Muth, A.N.; Lee, T.H.; Miano, J.M.; Ivey, K.N.; Srivastava, D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 2009, 460, 705-710.
92. Boettger, T.; Beet,z N.; Kostin, S.; Schneider, J.; Krüger, M.; Hein, L.; Braun, T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest., 2009, 119, 2634-2647.
93. Xin, M.; Smallm E,M,; Sutherland, L.B.; Qi, X.; McAnally, J.; Plato, C.F.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev., 2009, 23, 2166-2178.
94. Elia, L.; Quintavalle, M.; Zhang, J.; Contu, R.; Cossu, L.; Latronico, M.V.; Peterson, K.L.; Indolfi, C.; Catalucci, D.; Chen, J.; Courtneidge, S.A.; Condorelli, G. The knockout of miR-143 and - 145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ., 2009, 16, 1590-159.
95. Lovren, F.; Pan, Y.; Quan, A.; Singh, K.K.; Shukla, P.C.; Gupta, N.; Steer, B.M.; Ingram, A.J.; Gupta, M.; Al-Omran, M.; Teoh, H.; Marsden, P.A.; Verma, S. MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation, 2012, 126, S81-S90.
96. Boettger, T.; Beetz, N.; Kostin, S.; Schneider, J.; Krüger, M.; Hein, L.; Braun, T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest., 2009, 119, 2634-2647.
97. Nazari-Jahantigh, M.; Wei, Y.; Schober, A. The role of microRNAs in arterial remodelling. Thromb. Haemost., 2012, 107, 611-618.
98. Yang, K.; He, Y.S.; Wang, X.Q.; Lu, L.; Chen, Q.J.; Liu, J.; Sun, Z.; Shen, W.F. MiR-146a inhibits oxidized low-density lipoproteininduced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett., 2011, 585, 854-860.
99. O'Neill, L.A.; Sheedy, F.J.; McCoy, C.E. MicroRNAs: the finetuners of Toll-like receptor signalling. Nat. Rev. Immunol., 2011, 11, 163-175.
100. Graff, J.W.; Dickson, A.M.; Clay, G.; McCaffrey, A.P.; Wilson, M.E. Identifying functional microRNAs in macrophages with polarized phenotypes. J. Biol. Chem., 2012, 287, 21816-21825.
101. Androulidaki, A.; Iliopoulos, D.; Arranz, A.; Doxaki, C.; Schworer, S.; Zacharioudaki, V.; Margioris, A.N.; Tsichlis, P.N.; Tsatsanis, C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity, 2009, 31, 220-231.
102. Xu, C.; Ren, G.; Cao, G.; Chen, Q.; Shou, P.; Zheng, C.; Du, L.; Han, X.; Jiang, M.; Yang. Q.; Lin, L.; Wang, G.; Yu, P.; Zhang, X.; Cao, W.; Brewer, G.; Wang, Y.; Shi, Y. MiR-155 Regulates Immune Modulatory Properties of Mesenchymal Stem Cells by Targeting TAK1-binding Protein 2. J. Biol. Chem., 2013, 288, 11074-11079.
103. Nazari-Jahantigh, M.; Wei, Y.; Noels, H.; Akhtar, S.; Zhou, Z.; Koenen, R.R.; Heyll, K.; Gremse, F.; Kiessling, F.; Grommes, J.; Weber, C.; Schober, A. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest., 2012, 122, 4190-4202.
104. Cobb, B.S.; Hertweck, A.; Smith, J.; O'Connor, E.; Graf, D.; Cook, T.; Smale, S.T.; Sakaguchi, S.; Livesey, F.J.; Fisher, A.G.; Merkenschlager, M. A role for Dicer in immune regulation. J. Exp. Med., 2006, 203, 2519-2527.
105. Marson, A.; Kretschmer, K.; Frampton, G.M.; Jacobsen, E.S.; Polansky, J.K.; MacIsaac, K.D.; Levine, S.S.; Fraenkel, E.; von Boehmer, H.; Young, R.A. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature, 2007, 445, 931-935.
106. Zheng, Y.; Josefowicz, S.Z.; Kas, A.; Chu, T.T.; Gavin, M.A.; Rudensky, A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature, 2007, 445, 936-940.
107. Kohlhaas, S.; Garden, O.A.; Scudamore, C.; Turner, M.; Okkenhaug, K.; Vigorito, E. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol., 2009, 182, 2578-2582.
108. Yang, K.; He, Y.S.; Wang, X.Q.; Lu, L.; Chen, Q.J.; Liu, J.; Sun, Z.; Shen, W.F. MiR-146a inhibits oxidized lowdensity lipoproteininduced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett., 2011, 585, 854-860.
109. Nazari-Jahantigh, M.; Wei, Y.; Schober, A.; The role of microRNAs in arterial remodelling. Thromb. Haemost., 2012, 107, 611-618.
110. Roselaar, S.E.; Kakkanathu, P.X.; Daugherty, A. Lymphocyte populations in atherosclerotic lesions of apoE-/- and LDL receptor-/- mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol., 1996, 16, 1013-1018.
111. Huang, R.S.; Hu, G.Q.; Lin, B.; Lin, Z.Y.; Sun, C.J. MicroRNA- 155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. Investig. Med., 2010, 58, 961-967.
112. Nazari-Jahantigh, M.; Wei, Y.; Noels, H.; Akhtar, S.; Zhou, Z.; Koenen, R.R.; Heyll, K.; Gremse, F.; Kiessling, F.; Grommes, J.; Weber, C.; Schober, A. J. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest., 2012, 122, 4190-4202.
113. Foks, A.C.; Frodermann, V.; ter Borg, M.; Habets, K.L.; Bot, I.; Zhao, Y.; van Eck, M.; van Berkel, T.J.; Kuiper, J.; van Puijvelde, G.H. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis, 2011, 218, 53-60.
114. Donners, M.M.; Wolfs, I.M.; Stöger, L.J.; van der Vorst, E.P.; Pöttgens, C.C.; Heymans, S.; Schroen, B.; Gijbels, M.J.; de Winther, M.P. Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice. PLoS One, 2012, 7, e35877.
115. Fichtlscherer, S.; De Rosa, S.; Fox, H.; Schwietz, T.; Fischer, A.; Liebetrau, C.; Weber, M.; Hamm, C.W.; Röxe, T.; Müller- Ardogan, M.; Bonauer, A.; Zeiher, A.M.; Dimmeler, S. Circulating microRNAs in patients with coronary artery disease. Circ. Res., 2010, 107, 677-684.
116. Fichtlscherer, S.; Zeiher, A.M.; Dimmeler, S. Circulating microRNAs: biomarkersor mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol., 2011, 31, 2383-2390.
117. Wang, Y.S.; Wang, H.Y.; Liao, Y.C.; Tsai, P.C.; Chen, K.C.; Cheng, H.Y.; Lin, R,T,; Juo, S.H. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc. Res., 2012, 95, 517-526.
118. Porrello, E.R.; Johnson, B.A.; Aurora, A.B.; Simpson, E.; Nam, Y.J.; Matkovich, S.J.; Dorn, G.W 2nd. van Rooij, E.; Olson, E.N. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res., 2011, 109, 670-679.
119. Montgomery, R.L.; Hullinger, T.G.; Semus, H.M.; Dickinson, B.A.; Seto, A.G.; Lynch, J.M.; Stack, C.; Latimer, P.A.; Olson, E.N.; van Rooij, E. Therapeutic inhibition of mir-208a improves cardiac function and survival during heart failure. Circulation, 2011, 14, 1537-1547.
120. van Rooij, E.; Sutherland, L.B.; Qi, X.; Richardson, J.A.; Hill, J.; Olson, E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007, 316, 575-579.
121. Jayawardena, T.M.; Egemnazarov, B.; Finch, E.A.; Zhang, L.; Payne, J.A.; Pandya, K.; Zhang, Z.; Rosenberg, P.; Mirotsou, M.; Dzau, V.J. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res., 2012, 110, 1465-1473.
122. Wei, Y.; Nazari-Jahantigh, M.; Chan, L.; Zhu, M.; Heyll, K.; Corbalán-Campos, J.; Hartmann, P.; Thiemann, A.; Weber, C.; Schober, A. The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155- Dependent Pathway During Atherosclerosis. Circulation, 2013, 127, 1609-1619.
123. Isner, J.M.; Kearney, M.; Bortman, S.; Passeri, J. Apoptosis in human atherosclerosis and restenosis. Circulation, 1995, 91, 2703-2711.
124. Bennett, M.R.; Evan, G.I.; Schwartz, S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest., 1995, 95, 2266-2274.
125. Thorp, E.; Li, Y.; Bao, L.; Yao, P.M.; Kuriakose, G.; Rong, J.; Fisher, E.A.; Tabas, I. Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe-/- mice lacking macrophage Bcl-2. Arterioscler. Thromb. Vasc. Biol., 2009, 29, 169-172.
126. Meilhac, O.; Escargueil-Blanc, I.; Thiers, J.C.; Salvayre, R.; Négre- Salvayre, A. Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J., 1999, 13, 485-494.
127. Qin, B.; Xiao, B.; Liang, D.; Xia, J.; Li, Y.; Yang, H. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem. Biophys. Res. Commun., 2011, 410, 127-133.
128. Liu, M.E.; Liao, Y.C.; Lin, R.T.; Wang, Y.S.; His, E.; Lin, H.F.; Chen, K.C.; Juo, S.H. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis. Atherosclerosis, 2013, 228, 161-167.
129. Dentelli, P.; Rosso, A.; Orso, F.; Olgasi, C.; Taverna, D.; Brizzi, M.F. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 1562-1568.
130. Zhang, M.; Liu, Q.; Mi, S.; Liang, X.; Zhang, Z.; Su, X.; Liu, J.; Chen, Y.; Wang, M.; Zhang, Y.; Guo, F.; Zhang, Z.; Yang, R. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloidderived suppressor cells by modulating STAT3 expression. J. Immunol., 2011, 186, 4716-4724.
131. Rink, C.; Khanna, S. MicroRNA in ischemic stroke etiology and pathology. Physiol. Genom., 2011, 43, 521-528.
132. Salvatori, B.; Iosue, I.; Mangiavacchi, A.; Loddo, G.; Padula, F.; Chiaretti, S.; Peragine, N.; Bozzoni, I.; Fazi, F.; Fatica, A. The microRNA- 26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis., 2012, 3, e413.
133. Deiuliis, J.; Mihai, G.; Zhang, J.; Taslim, C.; Varghese, J.J.; Maiseyeu, A.; Huang, K.; Rajagopalan, S. Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. J. Hum. Hypertens., 2013, doi: 10.1038/jhh.2013.97. [Epub ahead of print]
134. Chen, K.C.; Wang, Y.S.; Hu, C.Y.; Chang, W.C.; Liao, Y.C.; Dai, C.Y.; Juo, S.H. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J., 2011, 25, 1718-1728.
135. Arner, E.; Mejhert, N.; Kulyté, A.; Balwierz, P.J.; Pachkov, M.; Cormont, M.; Lorente-Cebrián, S.; Ehrlund, A.; Laurencikiene, J.; Hedén, P.; Dahlman-Wright, K.; Tanti, J.F.; Hayashizaki, Y.; Rydén, M.; Dahlman, I.; van Nimwegen, E.; Daub, C.O.; Arner, P. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes, 2012, 61, 1986-1993.
136. Zhou, J.; Li, Y.S.; Nguyen, P.; Wang, K.C.; Weiss, A.; Kuo, Y.C.; Chiu, J.J.; Shyy, J.Y.; Chien, S. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ. Res., 2013, 113, 40-51.
137. Serva, A.; Knapp, B.; Tsai, Y.T.; Claas, C.; Lisauskas, T.; Matula, P.; Harder, N.; Kaderali, L.; Rohr, K,; Erfle, H.; Eils, R.; Braga, V.; Starkuviene, V. miR-17-5p regulates endocytic trafficking through targeting TBC1D2/Armus. PLoS One, 2012, 7, e52555.
138. Fang Y, Davies PF. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler. Thromb. Vasc. Biol., 2012, 32, 979-987.
139. Kim, J.; Kang, Y.; Kojima, Y.; Lighthouse, J.K.; Hu, X.; Aldred, M.A.; McLean, D.L.; Park, H.; Comhair, S.A.; Greif, D.M.; Erzurum, S.C.; Chun, H.J. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat. Med., 2013, 19, 74-82.
140. Leeper, N.J.; Raiesdana, A.; Kojima, Y.; Chun, H.J.; Azuma, J.; Maegdefessel, L.; Kundu, R.K.; Quertermous, T.; Tsao, P.S.; Spin, J.M. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J. Cell Physiol., 2011, 226, 1035-1143.
141. Hulsmans, M.; Holvoet, P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc. Res., 2013, 100, 7-18.
142. Wang, J.; Yan, C.H.; Li, Y.; Xu, K.; Tian, X.X.; Peng, C.F.; Tao, J.; Sun, M.Y.; Han, Y.L. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp. Cell Res., 2013, 319, 1165-1175.
143. Grundmann, S.; Hans, F.P.; Kinniry, S.; Heinke, J.; Helbing, T.; Bluhm, F.; Sluijter, J.P.; Hoefer, I.; Pasterkamp, G.; Bode, C.; Moser, M. MicroRNA-100
144. Hergenreider, E.; Heydt, S.; Tréguer, K.; Boettger, T.; Horrevoets, A.J.; Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler, S. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol., 2012, 14, 249-256.
145. Cheng, H.S.; Sivachandran, N.; Lau, A.; Boudreau, E.; Zhao, J.L.; Baltimore, D.; Delgado-Olguin, P.; Cybulsky, M.I.; Fish, J.E. MicroRNA- 146 represses endothelial activation by inhibiting proinflammatory pathways. EMBO Mol. Med., 2013, 5, 949-966.
146. Zhu H, Yang Y, Wang Y, Li J, Schiller PW, Peng T. MicroRNA- 195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc. Res., 2011, 92, 75-84.
147. Sarkar, S.; Dubaybo, H.; Ali, S.; Goncalves, P.; Kollepara, S.L.; Sethi, S.; Philip, P.A.; Li, Y. Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am. J. Cancer Res., 2013, 3, 465-477.
148. Raitoharju, E.; Oksala, N.; Lehtimäki, T. MicroRNAs in the Atheroclerotic Plaque. Clin. Chem. 2013, 59, 1708-1721.
149. Ferraro, A.; Kontos, C.; Boni, T.; Bantounas, I.; Siakouli, D.; Kosmidou, V.; Vlassi, M.; Spyridakis, Y.; Tsipras, I.; Zografos, G.; Pintzas, A. Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR- 21-ITG-4-PCDC4) as predictor of metastatic tumor potential. Epigenetics, 2013, 9, [Epub ahead of print]
150. Boon, R.A.; Hergenreider, E.; Dimmeler, S. Atheroprotective mechanisms of shear stress-regulated microRNAs. Thromb. Haemost., 2012, 108, 616-620.
151. Li, L.; Chen, X.P.; Li, Y.J. MicroRNA-146a and human disease. Scand. J. Immunol., 2010, 71, 227-231.
152. Nagy, B. Jr.; Miszti-Blasius, K.; Kerenyi, A.; Clemetson, K.J.; Kappelmayer, J. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation. Curr. Med. Chem., 2012, 19, 518-531.
153. Kampoli, A.M.; Tousoulis, D.; Papageorgiou, N.; Pallatza, Z.; Vogiatzi, G.; Briasoulis, A.; Androulakis, E.; Toutouzas, C.; Stougianos, P.; Tentolouris, C.; Stefanadis, C. Clinical utility of biomarkers in premature atherosclerosis. Curr. Med. Chem., 2012, 19, 2521-2533.